Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Biohaven names Coric chair, Buten CFO

Plus: Mutamba joins Arrakis as CBO and updates from Goldfinch, Kymera, AnHeart and more

December 7, 2021 2:38 AM UTC

Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHVN) appointed CEO Vlad Coric as chairman, following the retirement of Declan Doogan. The company also hired Matthew Buten as CFO, effective by Dec. 20, following the retirement of James Engelhart. Buten previously served as a healthcare portfolio manager at Catapult/Millennium Partners, and co-founded the healthcare funds Sapphire Capital and Argus Partners. 

Arrakis Therapeutics Inc. hired James Mutamba as chief business officer. Mutamba was previously VP at Pyxis Oncology Inc. (NASDAQ:PYXS). Arrakis is developing small molecule medicines that directly target RNA. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article